Upload
lungileshoba
View
440
Download
0
Embed Size (px)
DESCRIPTION
Description of activities of the Technology Innovation Agency in Industrial Biotechnology
Citation preview
Industrial Biotechnologies
For Climate Change
COP 17Lungile Shoba-Zikhali
(GM – Industrial Biotechnology)
06 Dec 2011 Lungile Shoba-Zikhali 2
Technology Innovation Agency (TIA)
www.akasan.com.tr/resimler/vision-mission-big.jpg
TIA VISION
…A world class innovation agency that supports and enables
technological innovation to achieve socio-economic benefits for South
Africa through leveraging strategic partnerships.
06 Dec 2011 Lungile Shoba-Zikhali 3
Formation of the TIA
06 Dec 2011 Lungile Shoba-Zikhali 4
The Innovation chasm challenge
Research Development Manufacturing
Local
Knowledge
Local Industry
OVERSEAS TECHNOLOGY SOURCES
Research Development Production
Innovation
“Chasm”
IP Lost
Large balance of
payment
06 Dec 2011 Lungile Shoba-Zikhali 5
The innovation chasm- the strategic
challenge continued
THE
IDEAS, RESEARC
H AND
DEVELOPMENT
COMMERCIAL
INDUSTRIES AND
MANUFACTURING
VALLEY OF DEATH
06 Dec 2011 Lungile Shoba-Zikhali 6
TIA
COMMERCIAL
INDUSTRIALISTRIES
AND
MANUFACTURING
THE IDEAS,
RESEARCH AND
DEVELOPMENT
TIA: Bridging the innovation chasm
06 Dec 2011 Lungile Shoba-Zikhali 7
MANDATE:
“…to support the State in stimulating and intensifying technological
innovation in order to improve economic growth and the quality of life
of all South Africans by „supporting & facilitating‟ the development and
exploitation of technological innovations”
The TIA Act [No 26 of 2008]
The TIA Mandate
06 Dec 2011 Lungile Shoba-Zikhali 8
PPP‟s
Private
Equity
Basic Research Applied Research Tech Development Manufacturing
IP V
alu
e
TIA Funding Focus
Low Risk/
High Return
High Risk/
Uncertain Return
CoCs
TIA geared towards addressing “market failure”
and building bridges and institutional linkages
along the innovation value chain:
Partnerships
(e.g. IDC, NEF)Partnerships
(e.g. NRF)
The TIA focuses its financial and non-financial offerings along the innovation chasm, and
operates with the required flexibility across the innovation value chain through mobilising
and leveraging national, regional and international partnerships
TIA Funding Focus
06 Dec 2011 Lungile Shoba-Zikhali 9
TIA Sectors
Agro HealthIndustrial
Biotechnology
Biotechnology
Sectors
Industrial
Sectors
TIA SECTORS
EnergyMiningAdvanced
Manufacturing ICT …Other
… Fund Management; Expert Services; IP; Finance; PPM&E…
06 Dec 2011 Lungile Shoba-Zikhali 10
Source:http://www.istockphoto.com/file_thumbview_approve/8453530/2/istockphoto_8453530-green-biofuel.jpg
INDUSTRIAL
BIOTECHNOLOGY
Industrial Biotechnology (IB)
Working definition:
“the application of biotechnology for the environmentally friendly
production of products and processing of chemicals, pharmaceuticals,
materials and bio-energy”.
(OECD Workshop on “Outlook on Industrial Biotechnology”. Discussion paper –Session II “Industry Structure and Business Models for Industrial Biotechnology”. 13-15 Jan 2010)
06 Dec 2011 Lungile Shoba-Zikhali 11
• Provides an opportunity to develop a sustainable, bio-based economy that uses
eco-efficient bio-processes and renewable bio-resources.
• Focuses on development of processes and production systems that:
- save costs and are more profitable since they do not waste material
-enable greater and more efficient utilization of renewable resources.
• Products that are:
-better performing, more durable and don’t persist after their useful life
-less toxic, more easily recyclable and biodegradable
-are derived from renewable resources
-contribute minimally to net greenhouse gas emission
Industrial Biotechnology (IB)
06 Dec 2011 Lungile Shoba-Zikhali 12
Drivers
• Less energy
• Less waste
- i.e. Cleaner production
Hurdles
• Further technology development
• Waste management
Drivers
• Knowledge-based quality jobs
• Social responsibility
Hurdles
• Unawareness
• Acceptance
Drivers
• Cost reduction
• Novel products
Hurdles
• Regulations
• Further technology development
• Feedstock prices
• Investments
SUSTAINABILITY
…to achieve the „Triple Bottom Line‟
…3Ps of Sustainability
Why Industrial Biotechnology?…Greening the SA economy for sustainable industrial
development
06 Dec 2011 Lungile Shoba-Zikhali 13
Industrial Biotech
Cross-Cutting Technology Sector
06 Dec 2011 Lungile Shoba-Zikhali 14
IB = cross-cutting „technology sector‟
…applies biotechnologies (microbial, plant and animal) for:
1. processing and
2. production of:
(Bio) Chemicals
(Bio) Materials
(Bio) Energy
across a diverse range of industry/economic sectors:
Application of IB
e.g. Sectors where
IB plays a roles
Pharmaceutical
Agriculture
Energy
Food & Beverage
Chemicals
Pulp & Paper
Plastics
Mining
Textiles
06 Dec 2011 Lungile Shoba-Zikhali 15
IB Value Chain
06 Dec 2011 Lungile Shoba-Zikhali 16
IB Sub-Sector Focus Areas
06 Dec 2011 Lungile Shoba-Zikhali 17
IB Sector Unit Objectives
1. Stimulate and support the development of industrial biotechnology-
based innovations for the environmentally friendly processing and
production of chemicals, materials and energy
2. Stimulate and support the development of industrial biotechnology-
based private and/or public enterprises
3. Leverage the TIA funds for co-investment into industrial biotechnology-
based innovations
06 Dec 2011 Lungile Shoba-Zikhali 18
4. Facilitate the development of human capital for technology innovation
within industrial biotechnology investments to ensure sufficient firm and/or
industry absorptive capacity* for new technologies
5. Promote and support activities and events that facilitate the building of a
culture of technology innovation and entrepreneurship
*“ability to recognize the value of a new „technology‟, assimilate it, and apply it to commercial ends” Cohen and Levinthal
(1990), "Absorptive capacity: A new perspective on learning and innovation", Administrative Science Quarterly, Volume 35, Issue 1 pg.
128-152.
IB Sector Unit Objectives
06 Dec 2011 Lungile Shoba-Zikhali 19
1. BioChemicals:
Products/processes with superior cost/performance ratio, e.g. enzymes in
bioprocesses
2. BioMaterials:
Production of eco-efficient materials e.g. biodegradable
3. BioEnergy:
Technologies for efficient conversion of biomass feedstock for energy production
4. BioRemediation:
Technologies for effective & cost-efficient treatment and recycling of wastewater
for improved water quality and reduced pollution/toxicity
5. BioMinerals:
Technologies for efficient & cost-effective bio-leaching/mining processes for
extracting mineral resources
IB Sub-sectors
06 Dec 2011 Lungile Shoba-Zikhali 20
OUTCOMES IMPACT
1
Increased application of biotechnology
in the process steps for the production of
chemicals and materials
Enhanced competitiveness of industries
Eco-efficient use of the renewable raw
materials
Sustainable industries less reliant on limited
fossil fuels
Economically & environmentally sustainable
manufacture of products
SA’s dependency on fossil fuels reduced
SA’s import of fuels reduced
Meaningful job creation
Improved standards of living for all SAs
Reduced waste generation
Reduced production of greenhouse gases
Increased contribution to the national GDP
Enhanced global competitiveness of South
African firms & industries
2Increased use of renewable resources
as raw materials for industrial applications
3
Increased application of biotechnology
in the manufacture of products across
various industries
4
Increased production of biomass-
derived energy based on biotechnology
for everyday consumption
5
Increased rural development that
contributes to the supply of raw renewable
materials
6
Increased cooperation, collaboration
and support between researchers,
industry, government & civil society
Expected Outcomes & Impact
of IB Innovation in SA
06 Dec 2011 Lungile Shoba-Zikhali 21
Distribution by Focus Area
0
5
10
15
20
25
30
35
Biochemicals Biomaterials Bioenergy Bioremediation Other
All
Current
Completed
Pipeline
06 Dec 2011 Lungile Shoba-Zikhali 22
1. Rabivir Green PharmProduction of anti-bodies in plant systems for the
development of therapeutics & diagnostics
2. AzarGen Production of high value therapeutic peptides in plants
3. FemTechDevelopment & optimisation of a fermentation technology for
the production of human recombinant proteins
4. HaloduransDevelopment & optimization of a recombinant technology for
the production of therapeutic peptides.
5. Enzyme Technologies Production of bromelain enzyme from pineapples
6. ZA BiotechCommercialisation of locally produced enzymes and
proprietary enzyme immobilisation technologies
7. Lactase Enzyme
(SLIEK)
Development of a fermentation bioprocess technology for
lactase production
Examples of TIA IB Investments
06 Dec 2011 Lungile Shoba-Zikhali 23
8. Algal Bioprospecting
Explore & characterize SA’s algal biodiversity and development
a collection and database of algal strains for the production of
biofuels
9. Indigenous FungiScreening & classifying (database) fungi culture collections for
value adding products
10. Algal Omega 3Validation of initial techno-economics of EPA/Omega 3
production by SA's algal strains
11. OM3 OilsValidation of technology for fish waste beneficiation (omega 3 oil
extraction)
12. Food and Cosmetic
TechnologiesDevelopment of novel formulation of low glycemic index sugar
13. Acid Mine Drainage
Development of technology for the neutralisation of acid mine
water and the biological removal of sulphate using sulphate
reducing bacteria
Examples of TIA IB Investments
06 Dec 2011 Lungile Shoba-Zikhali 24
Basic Research
Idea Generation
Proof of Concept
Technical development/
commercial planning
Product & business
development
Business start up
(tech based)
AzarGen RabiVir Femtech
Halodurans
ZA Biotech
Lactase Enzyme
(SLIEK)
Enzyme
Technologies
Algal
Bioprospecting
Indigenous
Fungi
Algal
Omega-3
Food & Cosmetic
TechnologiesOM3 Oils
Acid Mine
Drainage
Stage in the Innovation & Funding Value Chain
DoE, NRF, DST TIA Support IDC , NEF
Business growth
Seed Start-upEarly
ExpansionExpansion
Phase 1 Phase 2 Phase 3 Phase 4
06 Dec 2011 Lungile Shoba-Zikhali 25
What the IB Sector Unit is looking for
in Opportunities
1. Technology Innovation opportunity – Science-based product/process/service
offering with strong potential for market capitalisation
2. Strong alignment with the TIA mandate, Corporate and Sector Strategic objectives
3. Stage of technology development is beyond basic research (validated post-proof
of concept)
4. Potential for high socio-economic impact – addresses national imperatives e.g.
job creation
5. Strong potential to enhance industry competitiveness
6. Presence of an industry commercialisation partner where relevant
7. Co-Investment opportunity presented to allow risk-sharing
06 Dec 2011 Lungile Shoba-Zikhali 26
Thank you
www.tia.org.za